Health Canada
- Status: approved
🇨🇦 Pharmacological cardioversion with Refralon in Canada
Pharmacological cardioversion with Refralon (Pharmacological cardioversion with Refralon) regulatory status in Canada.
Marketing authorisation
Pharmacological cardioversion with Refralon in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is Pharmacological cardioversion with Refralon approved in Canada?
Yes. Health Canada has authorised it.
Who is the marketing authorisation holder for Pharmacological cardioversion with Refralon in Canada?
National Medical Research Center for Cardiology, Ministry of Health of Russian Federation is the originator. The local marketing authorisation holder may differ — check the official source linked above.